[ Price : $8.95]
Pozen says it has submitted a full response to a recent approvable letter on migraine drug Trexima.[ Price : $8.95]
FDA warns Chinas Northeast General Pharmaceutical Factory on cGMP deviations at its Shenyang API manufacturing facility[ Price : $8.95]
A Minnesota judge dismisses a suit claiming Wyeths Premarin and Prempro caused breast cancer for lack of scientifically valid evid...[ Price : $8.95]
FDA clears a StemCor Systems 510(k) for the MarrowMiner, intended for use in harvesting bone marrow.[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on public availability of advisory committee members financial interest inf...[ Price : $8.95]
MedTrackAlert says consumers respond best to ads that are relevant and deal with disease symptoms.[ Price : $8.95]
FDA approves an Allergan NDA for Combigan, indicated for reducing elevated intraocular pressure in patients with glaucoma or ocula...[ Price : $8.95]
BioDelivery Sciences International submits an NDA for Bema (fentanyl), indicated for treating breakthrough cancer pain.